Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

President Obama, Pelosi inaccurately respond: Health bills do not fund abortion

Yesterday members of Congress attended the White House Summit on Health Care Legislation. Responding to a claim by Minority Leader John Boehner that the health care legislation will fund abortion, President Obama dismissed it as talking points and "untrue." Speaker Pelosi also inaccurately responded that the health bills do not fund abortion.

27 Feb 2010

Partisanship peaks at health summit, Democrats likely to go it alone

Thursday's bipartisan health summit ended with the partisan rift intact, increasing the possibility that President Barack Obama will try to unify Democrats to pass legislation without GOP support.

26 Feb 2010

Making public policies on vaccination with limited information

"Let's say you're a public health official from the Centers for Disease Control, and you don't really know how much disease is going to be averted by vaccinating different fractions of the population," said Manski, the Board of Trustees Professor in Economics in the Weinberg College of Arts and Sciences. "Then how should you choose a policy? That's really what the paper tries to address."

26 Feb 2010

Mathematics of sleep-wake cycle

Why can't I fall asleep? Will this new medication keep me up all night? Can I sleep off this cold? Despite decades of research, answers to these basic questions about one of our most essential bodily functions remain exceptionally difficult to answer. In fact, researchers still don't fully understand why we even sleep at all. In an effort to better understand the sleep-wake cycle and how it can go awry, researchers at Rensselaer Polytechnic Institute are taking a different approach than the traditional brain scans and sleep studies. They are using mathematics.

26 Feb 2010

Texas Plant-Expressed Vaccine Consortium announces biotherapeutic manufacturing initiative for infectious diseases

Leaders of the Texas Plant-Expressed Vaccine Consortium today announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation's capability to produce vaccines for infectious diseases, including influenza.

25 Feb 2010

Texas-based consortium announces biotherapeutic manufacturing initiative for vaccine production

25 Feb 2010

CDC ACIP's vote for universal influenza vaccination recommendation: FFF endorses

Families Fighting Flu (FFF) fully supports today's vote by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) to expand the current influenza vaccination recommendations to include all adults aged 19 to 49 years of age. Previous recommendations included all other age groups with the exception of this new adult population. This new recommendation will be implemented beginning with the 2010-2011 influenza season.

25 Feb 2010

HealthGrades America’s 50 Best Hospitals for 2010 identified

The HealthGrades America’s 50 Best Hospitals for 2010 were identified in a report issued today by the leading independent healthcare ratings organization. The analysis, which examined objective patient outcomes over three years at all 5,000 of the nation’s nonfederal hospitals, found that the 50 Best Hospitals had mortality rates that were, on average, 27% lower than other hospitals.

25 Feb 2010

Lease of Stevens Hospital by Swedish approved

The Board of Commissioners for Public Hospital District #2 of Snohomish County today approved an agreement for Swedish to lease and assume management of Stevens Hospital. The last phase before transition involves regulatory approvals which could be completed by early fall.

25 Feb 2010

American Lung Association supports ACIP's recommendations for universal influenza immunization

The American Lung Association supports the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices' (ACIP) vote today that recommends universal influenza immunization with seasonal influenza vaccine.

25 Feb 2010

Mariner to present HAI controlling dashboard at 2010 Microsoft Health User Group Exchange

Mariner, an industry-leading business intelligence, performance management and analytics solutions provider, will present an exciting new data-driven dashboard at the Microsoft Health User Group Exchange 2010 taking place during HIMSS10 at the Georgia World Conference Center in Atlanta, Georgia, February 28th. Designed to help the medical center’s infection control practitioner’s control HAIs, the Dashboard has been the subject of recent POC activity at Wake Forest University Baptist Medical Center (WFUBMC).

25 Feb 2010

Chilean hospital's early use of antiviral treatment and aggressive measures helped reduce H1N1 cases

A Chilean hospital's early use of antiviral treatment in influenza patients and other aggressive measures helped reduce the number of severe H1N1 cases and related deaths. Those are the findings of a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650750), published in the March 15, 2010 issue of Clinical Infectious Diseases.

25 Feb 2010

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

Pfizer Inc. announced today that the United States Food and Drug Administration has granted approval for Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company’s 13-valent pneumococcal conjugate vaccine.

25 Feb 2010

Unique technology identifies drug candidates, speeds up drug development

The search for new therapeutic agents is time-consuming and expensive. Pharmaceutical companies may have to screen thousands of compounds for the ability to bind a target molecule before they hit upon a promising drug candidate.

From NanoTemper Technologies 24 Feb 2010

FDA approves Wyeth Pharmaceuticals' Prevnar 13 pneumococcal disease vaccine

The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.

24 Feb 2010

First convertible endotracheal tube launched by Teleflex Medical

Teleflex Medical has announced the introduction of the Teleflex ISIS™ HVT™, the first convertible endotracheal tube. The Teleflex ISIS HVT features an integrated suction port and separate suction line allowing for subglottic secretion suctioning on demand. Now clinicians can be free from the burden of choosing which tube is best for the patient at the time of intubation. When needed, the suction tube attaches to the Teleflex ISIS HVT via a secure locking connection.

24 Feb 2010

FDA's warning over LABA medications for asthma: AANMA offers guidance

Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair ® (fluticasone and salmeterol), Foradil ® (formoterol), Severent ® (salmeterol) and Symbicort ® (budesonide and formoterol), daily inhaled medications containing a long-acting beta agonist (LABA, a 12-hour bronchodilator).

24 Feb 2010

BioStorage Technologies' Frankfurt facility receives green certification from ENTEGA Vertrieb

BioStorage Technologies, a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, today announced its full-service biorepository near Frankfurt, Germany received green certification from ENTEGA Vertrieb GmbH & Co., a leading Germany-based sustainable energy supplier.

24 Feb 2010

HealthGrades names Good Samaritan Hospital as One of America’s 50 Best Hospitals in 2010

Good Samaritan Hospital in Los Angeles is named as One of America’s 50 Best Hospitals in 2010 by HealthGrades, Inc., the nation’s leading independent healthcare ratings organization.

24 Feb 2010

IBM Maximo software helps GNL ensure optimal performance of equipment in fight against emerging infectious diseases

In the fight against emerging infectious diseases, The Galveston National Laboratory (GNL), one of two National Institutes of Health funded bio-containment laboratories in the United States, is benefiting from IBM software to ensure the optimal performance of all equipment functioning within its facility. The GNL, which is dedicated to the study and prevention of emerging infectious diseases, will use IBM Maximo Asset Management Software to help automate, manage and ensure the performance of its 3,000 operating assets in one of the world's most complex medical research environments.

24 Feb 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

President Obama, Pelosi inaccurately respond: Health bills do not fund abortion

Partisanship peaks at health summit, Democrats likely to go it alone

Making public policies on vaccination with limited information

Mathematics of sleep-wake cycle

Texas Plant-Expressed Vaccine Consortium announces biotherapeutic manufacturing initiative for infectious diseases

Texas-based consortium announces biotherapeutic manufacturing initiative for vaccine production

CDC ACIP's vote for universal influenza vaccination recommendation: FFF endorses

HealthGrades America’s 50 Best Hospitals for 2010 identified

Lease of Stevens Hospital by Swedish approved

American Lung Association supports ACIP's recommendations for universal influenza immunization

Mariner to present HAI controlling dashboard at 2010 Microsoft Health User Group Exchange

Chilean hospital's early use of antiviral treatment and aggressive measures helped reduce H1N1 cases

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

Unique technology identifies drug candidates, speeds up drug development

FDA approves Wyeth Pharmaceuticals' Prevnar 13 pneumococcal disease vaccine

First convertible endotracheal tube launched by Teleflex Medical

FDA's warning over LABA medications for asthma: AANMA offers guidance

BioStorage Technologies' Frankfurt facility receives green certification from ENTEGA Vertrieb

HealthGrades names Good Samaritan Hospital as One of America’s 50 Best Hospitals in 2010

IBM Maximo software helps GNL ensure optimal performance of equipment in fight against emerging infectious diseases

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in